Other results included:

  • The strongest predictor of regular aspirin use was a patient having discussed aspirin therapy with a healthcare provider.
  • About 35% of respondents reporting regular aspirin use did not report objective risk factors in which aspirin therapy could provide a benefit.
  • Approximately 20% of respondents with a history of heart attack or stroke were not regularly taking aspirin.
  • A majority of current and previous aspirin users rated themselves as being somewhat or very knowledgeable about aspirin use.
  • Significant predictors of aspirin use included those who were physically active, ate healthy foods, had achieved a healthy weight, managed their stress, tried to quit smoking, and/or had undergone health screenings.

The U.S. Preventive Services Task Force (USPSTF) recommends daily aspirin for moderately high-risk individuals (including those with CVD risk factors such as hypertension, high cholesterol, smoking, or diabetes), but the U.S. Food and Drug Administration (FDA) does not recommend routine use for primary prevention. The FDA does state that it may be appropriate when prescribed by a healthcare provider to high-risk patients. Because aspirin is available over-the-counter (OTC) but correct use for primary prevention is complex, many patients could be inappropriately taking daily aspirin or high-risk patients may not be on a regimen. Clinicians should discuss regular aspirin use with their patients and recommend treatment based on existing risk factors after weighing the benefits and risks.

For more information visit AJPMOnline.org.